Anti-EBV Latent Membrane Protein 1 抗体 [CS 1-4] (ab78113)

ab78113 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab78113 は 9 報の論文で使用されています。

  • Martin KA  et al. Epstein-Barr Virus Oncoprotein LMP1 Mediates Epigenetic Changes in Host Gene Expression through PARP1. J Virol 90:8520-30 (2016). PubMed: 27440880
  • Campion EM  et al. Repression of the proapoptotic cellular BIK/NBK gene by Epstein-Barr virus antagonizes transforming growth factor ß1-induced B-cell apoptosis. J Virol 88:5001-13 (2014). PubMed: 24554662
  • Arredouani MS  et al. Analysis of host gene expression changes reveals distinct roles for the cytoplasmic domain of the Epstein-Barr virus receptor/CD21 in B-cell maturation, activation, and initiation of virus infection. J Virol 88:5559-77 (2014). PubMed: 24600013
  • Flanagan J  et al. Localization of the Epstein-Barr virus protein LMP 1 to exosomes. J Gen Virol 84:1871-9 (2003). PubMed: 12810882
  • Xu J  et al. Preferential localization of the Epstein-Barr virus (EBV) oncoprotein LMP-1 to nuclei in human T cells: implications for its role in the development of EBV genome-positive T-cell lymphomas. J Virol 76:4080-6 (2002). PubMed: 11907247
  • Nakatsuka S  et al. Pyothorax-associated lymphoma: a review of 106 cases. J Clin Oncol 20:4255-60 (2002). PubMed: 12377970
  • Ascani S  et al. Pyothorax-associated lymphoma: description of the first two cases detected in Italy. Ann Oncol 8:1133-8 (1997). PubMed: 9426333
  • Rowe M  et al. Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells. J Gen Virol 68 ( Pt 6):1575-86 (1987). PubMed: 2438376
  • Rowe M  et al. Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells. EMBO J 6:2743-51 (1987). PubMed: 2824192

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"